PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.
|
25561023 |
2015 |
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity.
|
24936070 |
2014 |
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
A novel α-synuclein missense mutation in Parkinson disease.
|
23427326 |
2013 |
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
|
23457019 |
2013 |
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
|
14755719 |
2004 |
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
|
9462735 |
1998 |
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
|
9197268 |
1997 |
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
Biomarker
|
disease |
CTD_human |
|
|
|
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Lewy Body Disease
|
0.800 |
Biomarker
|
disease |
CTD_human |
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein.
|
19628769 |
2009 |
Lewy Body Disease
|
0.800 |
Biomarker
|
disease |
CTD_human |
Preliminary analyses have identified 2 proteins with lipoxidative damage, alpha-synuclein and manganese superoxide dismutase (SOD2), in incidentally Lewy body disease cortex.
|
16141792 |
2005 |
Lewy Body Disease
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
|
14755719 |
2004 |
Lewy Body Disease
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Lewy Body Disease
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
We identified 13 common genes (ADARB2, CEACAM6, CNTNAP2, COL19A1, DEF4, DRAXIN, FCER2, HBG1, NCAPG2, PVRL2, SLC2A14, SNCA, and TCL1B) showing significant differential expression between G2019S-associated PD and asymptomatic carriers and also between idiopathic PD and controls but not between untreated and treated patients.
|
25475535 |
2015 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease.
|
25106480 |
2015 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
One major advance in this field has been the discovery of several genes associated to familial PD, including alpha synuclein, parkin, LRRK2, etc., thereby providing important insight toward basic research approaches.
|
25631236 |
2015 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese.
|
25149416 |
2014 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
|
25064009 |
2014 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway.
|
24833599 |
2014 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
The olfactory bulb (OB) is one of the first brain regions in Parkinson's disease (PD) to contain alpha-synuclein (α-syn) inclusions, possibly associated with nonmotor symptoms.
|
24509835 |
2014 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
Neuronal vulnerability in Parkinson's disease.
|
22166454 |
2012 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
GSM-900MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy.
|
22185909 |
2012 |
Parkinson Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
Mechanism of copper(II)-induced misfolding of Parkinson's disease protein.
|
22355530 |
2011 |